Vertex stock has climbed more than 60% over three years.
Which biotech company does Vertex admire? Hint: It’s one some analysts think the cystic fibrosis drugmaker should have snapped up a long time ago. The “analogy that we’ve often talked about is with ...
Vertex, Inc. (NASDAQ:VERX) Q4 2025 Earnings Call Transcript February 11, 2026 Vertex, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $0.17. Operator: Good day, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results